Skip to main content

Table 4 Summary of results of blood tests before and after the 2-week neuromuscular electric stimulation program

From: Therapeutic electric stimulation does not affect immune status in healthy individuals – a preliminary report

 

 Before NMES 

 After NMES 

Before vs. After (no. of cases)

 p 

 p 

Range

Mean

Range

Mean

<

=

>

(paired t )

(EWMPT)

Leucocytes

3.8 - 8.0

5.7

4.7 - 7.9

5.7

4

1

5

0.901

0.719

Neutrophils (%)

36.4 - 67.7

51.8

37.6 - 68.9

52.4

5

0

5

0.888

1.000

Neutrophils (no.)

1.4 - 5.4

3.0

2.2 - 5.4

3.1

5

0

5

0.967

0.695

Monocytes (%)

2.8 - 7.4

4.1

3.2 - 7.8

4.2

5

1

4

0.943

0.910

Monocytes (no.)

0.1 - 0.3

0.2

0.2 - 0.5

0.2

5

0

5

0.894

0.770

Lymphocytes (%)

28.3 - 54.6

38.8

25.8 - 51.1

37.9

4

0

6

0.792

1.000

Lymphocytes (no.)

1.7 - 2.9

2.2

1.8 - 3.0

2.2

2

0

8

0.725

0.375

CD3 (%)

60.0 - 84.0

72.4

61.0 - 87.0

75.6

6

3

1

0.088

0.078

CD3 (10 9 cells/L)

1.012 - 2.423

1.639

1.171 - 2.460

1.686

4

0

6

0.734

0.922

CD19 (%)

2.0 - 24.0

8.5

5.0 - 23.0

10.0

7

0

3

0.051

0.059

CD19 (10 9 cells/L)

0.042 - 0.398

0.184

0.102 - 0.442

0.218

8

0

2

0.065

0.064

CD4 (%)

31.0 - 56.0

43.5

36.0 - 62.0

47.6

6

2

2

0.128

0.117

CD4 (10 9 cells/L)

0.691 - 1.483

0.997

0.766 - 1.719

1.061

5

0

5

0.473

0.770

CD8 (%)

17.0 - 45.0

27.2

15.0 - 50.0

27.1

3

2

5

0.940

0.992

CD8 (10 9 cells/L)

0.282 - 1.298

0.626

0.288 - 1.371

0.616

5

0

5

0.779

0.846

CD4/8

0.7 - 2.6

1.7

0.7 - 3.9

1.9

6

1

3

0.289

0.359

DR/3 (%)

4.0 - 25.0

9.0

3.0 - 20.0

8.5

4

0

6

0.485

0.561

DR/3 (10 9 cells/L)

0.083 - 0.558

0.207

0.061 - 0.420

0.185

4

0

6

0.302

0.432

NK (%)

6.0 - 37.0

13.7

6.0 - 26.0

13.1

4

1

5

0.829

0.633

NK (10 9 cells/L)

0.159 - 0.776

0.303

0.178 - 0.572

0.288

4

0

6

0.780

0.557

Th reg (%)

0.8 - 4.0

1.8

0.1 - 5.0

2.1

5

2

3

0.328

0.344

Th reg (10 9 cells/L)

0.014 - 0.051

0.028

0.002 - 0.077

0.036

6

0

4

0.211

0.232

CD25 + CD3+ (%)

2.0 - 14.0

6.1

1.0 - 16.0

5.6

4

3

3

0.674

1.000

CD25 + CD3+ (10 9 cells/L)

0.042 - 0.294

0.136

0.018 - 0.325

0.125

5

0

5

0.691

1.000

CD25 + CD4+ (%)

3.0 - 24.0

11.5

1.0 - 24.0

11.0

5

2

3

0.805

0.938

CD25 + CD4+ (10 9 cells/L)

0.066 - 0.312

0.183

0.025 - 0.381

0.178

6

0

4

0.964

0.846

CD25 + CD8+ (%)

0.1 - 2.0

0.9

0.3 - 2.0

0.8

1

8

1

0.555

1.000

CD25 + CD8+ (10 9 cells/L)

0.001 - 0.034

0.015

0.004 - 0.049

0.016

4

0

6

0.751

1.000

CD69 + CD3+ (%)

1.0 - 8.0

2.8

1.0 - 4.0

2.2

3

5

2

0.363

0.625

CD69 + CD3+ (10 9 cells/L)

0.021 - 0.231

0.069

0.018 - 0.088

0.049

4

0

6

0.324

0.922

CD69 + CD4+ (%)

1.0 - 4.0

1.7

1.0 - 4.0

2.1

4

5

1

0.168

0.313

CD69 + CD4+ (10 9 cells/L)

0.010 - 0.081

0.031

0.012 - 0.062

0.036

6

0

4

0.412

0.432

CD69 + CD8+ (%)

1.0 - 4.0

2.4

1.0 - 4.0

2.0

3

2

5

0.309

0.344

CD69 + CD8+ (10 9 cells/L)

0.010 - 0.097

0.042

0.016 - 0.094

0.035

4

0

6

0.308

0.375

FTg (%)

84.3 - 97.1

90.5

84.1 - 97.0

91.5

5

0

5

0.334

0.322

FTm (%)

68.7 - 92.1

82.0

80.6 - 93.4

84.3

6

0

4

0.538

0.492

Ecg (%)

89.8 - 98.7

93.6

84.0 - 98.9

91.8

5

0

5

0.422

0.375

Ecm (%)

77.7 - 95.8

86.0

71.4 - 95.8

87.0

7

0

3

0.632

0.322

  1. EWMPT - exact Wilcoxon signed-rank matched-pairs test.